1. Home
  2. CKX vs ATHA Comparison

CKX vs ATHA Comparison

Compare CKX & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

N/A

Current Price

$9.26

Market Cap

19.5M

Sector

Energy

ML Signal

N/A

Logo Athira Pharma Inc.

ATHA

Athira Pharma Inc.

N/A

Current Price

$4.12

Market Cap

18.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CKX
ATHA
Founded
1930
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
18.2M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CKX
ATHA
Price
$9.26
$4.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.2K
19.2K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
2.14
N/A
EPS
0.23
N/A
Revenue
$897,333.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$41.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.66
$2.20
52 Week High
$14.00
$6.08

Technical Indicators

Market Signals
Indicator
CKX
ATHA
Relative Strength Index (RSI) 37.10 52.66
Support Level $9.15 $3.80
Resistance Level $9.67 $4.13
Average True Range (ATR) 0.44 0.25
MACD -0.01 -0.03
Stochastic Oscillator 33.52 39.35

Price Performance

Historical Comparison
CKX
ATHA

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: